Discontinuation: PenMix30 Penfill 3ml, NovoMix30 FlexPen 3ml, Actrapid Penfill 3ml and Protaphane Penfill 3ml.
- admin82291
- 22 hours ago
- 1 min read
Discontinuation:
We are writing to inform you that NovoNordisk are rationalising their product range and discontinuing four insulins. Please begin transitioning your patients to suitable alternatives.
Key Dates:
PenMix30 Penfill 3ml
Supply of the PenMix30 ended October 2025. The remaining stock expires in April 2026. This will be delisted (no longer funded) 1 May 2026.
Please see advice: NZSSD Guidance: Discontinuation of Penmix30 and Penmix50 and Mixtard 30, July 2024. Note this advice mentions Novomix30 as a possible replacement. However, Novomix30 will be discontinued later in 2026.
NovoMix30 FlexPen 3 ml prefilled disposable pen
The supplier will stop selling this product by the end of 2026.
From 1 May 2025, we have funded Ryzodeg which may be a suitable alternative to NovoMix 30.
Actrapid Penfill 3ml
The supplier will stop selling this product by the end of 2026.
Protaphane Penfill 3ml
The supplier will stop selling this product by the end of 2026.
More information is available on our website:
Insulin discontinuations on Pharmac website This will continue to be updated.
Questions:
If you have any queries, please contact us at enquiry@pharmac.govt.nz
Please share this information:
Please share this information with your colleagues and within your networks.
Ngā mihi,
Anna I Senior Advisor Implementation
Pharmac | Te Pātaka Whaioranga | PO Box 10 254 | Level 9, 40 Mercer Street, Wellington
P: 0800 660 050 | www.pharmac.govt.nz
Pharmac will be closed over the Christmas break from Thursday 25 December 2025, reopening Monday 5 January 2026.